Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a … – 7thSpace Interactive (press release)

Prospect of vasoactive intestinal peptide therapy for COPD/PAH and asthma: a
7thSpace Interactive (press release)
There is mounting evidence that pulmonary arterial hypertension (PAH), asthma and chronic obstructive pulmonary disease (COPD) share important pathological features, including inflammation, smooth muscle contraction and remodeling.

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *